David Massel

3.2k total citations · 1 hit paper
56 papers, 2.1k citations indexed

About

David Massel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Massel has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Massel's work include Acute Myocardial Infarction Research (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac Imaging and Diagnostics (8 papers). David Massel is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Cardiac Imaging and Diagnostics (8 papers). David Massel collaborates with scholars based in Canada, United States and United Kingdom. David Massel's co-authors include Jeffrey I. Weitz, Monika Hudoba, John M. Maraganore, J. Hirsh, Stephen H. Little, Lorne J. Gula, Raymond Yee, Allan C. Skanes, George J. Klein and Andrew D. Krahn and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

David Massel

53 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

1990 904 citations David Massel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Massel Canada	21	1.4k	786	490	411	229	56	2.1k
George Hahalis Greece	27	1.7k 1.2×	1.0k 1.3×	451 0.9×	362 0.9×	573 2.5×	121	2.9k
R.M. Califf United States	14	1.3k 0.9×	882 1.1×	272 0.6×	236 0.6×	107 0.5×	27	1.7k
Anupama Rao United States	16	1.0k 0.7×	527 0.7×	343 0.7×	186 0.5×	254 1.1×	51	1.5k
Alexander B.A. Vonk Netherlands	26	968 0.7×	1.0k 1.3×	218 0.4×	188 0.5×	236 1.0×	75	2.4k
Mamdouh Bakhos United States	29	1.0k 0.7×	1.3k 1.7×	411 0.8×	191 0.5×	373 1.6×	99	2.1k
Aun‐Yeong Chong Canada	24	1.3k 0.9×	717 0.9×	209 0.4×	72 0.2×	282 1.2×	100	2.1k
Stephen W. Waldo United States	25	1.1k 0.8×	1.2k 1.5×	153 0.3×	182 0.4×	704 3.1×	142	2.7k
Robert L. Thurer United States	27	927 0.6×	1.3k 1.6×	193 0.4×	363 0.9×	845 3.7×	77	2.9k
Filippo Ottani Italy	23	1.7k 1.1×	617 0.8×	160 0.3×	156 0.4×	192 0.8×	76	2.2k
John Ducas Canada	23	1.8k 1.2×	1.2k 1.5×	402 0.8×	144 0.4×	572 2.5×	99	2.9k

Countries citing papers authored by David Massel

Since Specialization

Citations

This map shows the geographic impact of David Massel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Massel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Massel more than expected).

Fields of papers citing papers by David Massel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Massel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Massel. The network helps show where David Massel may publish in the future.

Co-authorship network of co-authors of David Massel

This figure shows the co-authorship network connecting the top 25 collaborators of David Massel. A scholar is included among the top collaborators of David Massel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Massel. David Massel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romsa, Jonathan, Çiğdem Akincioğlu, James Warrington, et al.. (2015). Very high coronary artery calcium score with normal myocardial perfusion SPECT imaging is associated with a moderate incidence of severe coronary artery disease. European Journal of Nuclear Medicine and Molecular Imaging. 42(10). 1542–1550. 11 indexed citations

Khan, Razi, David Massel, John Stirrat, et al.. (2012). Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study. International journal of cardiac imaging. 29(2). 395–404. 10 indexed citations

Gula, Lorne J., David Massel, Peter Leong‐Sit, et al.. (2011). Does Adenosine Response Predict Clinical Recurrence of Atrial Fibrillation After Pulmonary Vein Isolation?. Journal of Cardiovascular Electrophysiology. 22(9). 982–986. 36 indexed citations

Gula, Lorne J., George J. Klein, Urszula Zurawska, et al.. (2009). Does Familiarity with Technology Predict Successful Use of an External Loop Recorder? The Loop Recorder Technology Cognition Study (LOCO). Pacing and Clinical Electrophysiology. 32(4). 466–472. 7 indexed citations

Gula, Lorne J., George J. Klein, Anne S. Hellkamp, et al.. (2008). Ejection fraction assessment and survival: An analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). American Heart Journal. 156(6). 1196–1200. 32 indexed citations

Gula, Lorne J., David Massel, Andrew D. Krahn, et al.. (2008). Is Defibrillation Testing Still Necessary? A Decision Analysis and Markov Model. Journal of Cardiovascular Electrophysiology. 19(4). 400–405. 27 indexed citations

Gula, Lorne J., David Massel, Andrew D. Krahn, et al.. (2007). Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls—Adding statistical insight to clinical intuition. American Heart Journal. 153(2). 253–259. 9 indexed citations

Massel, David. (2005). Primary angioplasty in acute myocardial infarction: Hypothetical estimate of superiority over aspirin or untreated controls. The American Journal of Medicine. 118(2). 113–122.

Tsui, Wai, et al.. (2005). Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.. PubMed. 21(5). 423–31. 4 indexed citations

10.

Huynh, Thao, Jafna L. Cox, David Massel, et al.. (2004). Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project. American Heart Journal. 148(1). 86–91. 33 indexed citations

11.

Trevithick, John R., et al.. (2004). Model study of AREDS antioxidant supplementation of AMD compared to Visudyne: A dominant strategy?. Ophthalmic Epidemiology. 11(5). 337–346. 18 indexed citations

12.

Massel, David. (2003). Observer Variability in ECG Interpretation for Thrombolysis Eligibility: Experience and Context Matter. Journal of Thrombosis and Thrombolysis. 15(3). 131–140. 17 indexed citations

13.

Little, Stephen H. & David Massel. (2003). Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database of Systematic Reviews. CD003464–CD003464. 31 indexed citations

14.

Gwadry‐Sridhar, Femida, et al.. (2003). Instruments to Measure Acceptability of Information and Acquisition of Knowledge in Patients with Heart Failure. European Journal of Heart Failure. 5(6). 783–791. 24 indexed citations

15.

Massel, David & Moira Cruickshank. (2002). Enoxaparin in acute coronary syndromes: Evidence for superiority over placebo or untreated control. American Heart Journal. 143(5). 748–752. 3 indexed citations

16.

Massel, David & Stephen H. Little. (2001). Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. Journal of the American College of Cardiology. 37(2). 569–578. 64 indexed citations

17.

Massel, David, et al.. (2000). Strict reliance on a computer algorithm or measurable ST segment criteria may lead to errors in thrombolytic therapy eligibility. American Heart Journal. 140(2). 221–226. 37 indexed citations

18.

Massel, David. (1993). How sound is the evidence that thrombolysis increases the risk of cardiac rupture?. Heart. 69(4). 284–287. 15 indexed citations

19.

Massel, David. (1991). Cardiac rupture and time to thrombolytic treatment. Journal of the American College of Cardiology. 17(7). 1671–1671. 3 indexed citations

20.

Massel, David, John B. Gill, & John A. Cairns. (1990). Management of the patient following coronary thrombolysis. Clinical Cardiology. 13(9). 591–609. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact